Vote on HB 240 - Shall CS FOR HOUSE BILL NO. 240(FIN) "An Act relating to prescription prices available to consumers; relating to penalties for certain pharmacy or pharmacist violations; relating to the registration and duties of pharmacy benefits managers; relating to procedures, guidelines, and enforcement mechanisms for pharmacy audits; relating to the cost of multi-source generic drugs and insurance reimbursement procedures; relating to the duties of the director of the division of insurance; and providing for an effective date" pass the Senate?

Pass
  • Bill: HB 240
  • Motion Text: Shall CS FOR HOUSE BILL NO. 240(FIN) "An Act relating to prescription prices available to consumers; relating to penalties for certain pharmacy or pharmacist violations; relating to the registration and duties of pharmacy benefits managers; relating to procedures, guidelines, and enforcement mechanisms for pharmacy audits; relating to the cost of multi-source generic drugs and insurance reimbursement procedures; relating to the duties of the director of the division of insurance; and providing for an effective date" pass the Senate?
  • Legislative Session: Alaska 30th Legislature (2017-2018)
  • Date: May 07, 2018
  • Outcome: Pass
Vote Totals
Yes 19
No 0
Other 1
Breakdown by Party Yes No Other
Democratic 5 0 0
Republican 12 0 1
Unknown 2 0 0

Roll Call


Name Party Vote
Tom Begich Democratic Yes
Click Bishop Republican Yes
John Coghill Republican Yes
Mia Costello Republican Yes
Dennis Egan Democratic Yes
Berta Gardner Democratic Yes
Cathy Giessel Republican Yes
Lyman Hoffman Democratic Yes
Shelley Hughes Republican Yes
Pete Kelly Republican Yes
Anna MacKinnon Republican Yes
Kevin Meyer Republican Yes
Peter Micciche Republican Yes
Bert Stedman Republican Yes
Gary Stevens Republican Yes
Bill Wielechowski Democratic Yes
Natasha von Imhof Republican Yes
Olson Yes
Wilson Yes
Mike Shower Republican Other

Sources

Data on Open States is updated periodically throughout the day from the official website of the Alaska State Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.